
Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers
Author(s) -
PingI Hsu,
GinHo Lo,
ChingChu Lo,
ChiunKu Lin,
HoiHung Chan,
Chung-Jen Wu,
ChangBih Shie,
Pei-Min Tsai,
Deng-Chyang Wu,
Wenming Wang,
Kwok–Hung Lai
Publication year - 2004
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v10.i24.3666
Subject(s) - pantoprazole , medicine , ranitidine , hemostasis , peptic , prospective cohort study , upper gastrointestinal bleeding , anesthesia , endoscopy , randomized controlled trial , surgery , gastroenterology , omeprazole , peptic ulcer
The role of intravenous pantoprazole in treatment of patients with high-risk bleeding peptic ulcers following endoscopic hemostasis remains uncertain. We therefore conducted the pilot prospective randomized study to assess whether intravenous pantoprazole could improve the efficacy of H(2)-antagonist as an adjunct treatment following endoscopic injection therapy for bleeding ulcers.